Chakra Biotech Sdn Bhd Changes Its Name to Cerca Insights Sdn Bhd
"The new name reinforces the value of our services," said Anthony Bishop, CEO of Cerca Insights. "Cerca, the Italian word for search, reflects our commitment to help pharma and biotech customers discover better medicines for patients, particularly those with psychiatric illness. Insights reflects our vision to provide customers a clear view of the clinical properties in their discovery stage compounds."
Cerca Insights continues to offer customers advanced, novel in-vivo efficacy models to discover, assess, and characterize discovery stage psychiatric and other CNS compounds.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.